Print Page      Close Window     

Investors

SEC Filings

6-K
OBSEVA SA filed this Form 6-K on 03/30/2018
Entire Document
 


LOGO

 

Results: Demographics and baseline characteristics      D3D5Pooled D3/D5 Nolasiban Nolasiban Nolasiban Mean (SD) UnitPlaceboPlacebo Placebo 900 mg900 mg900 mg Number ofn194194196194390388 subjects Ageyears31.4 (3.3)31.1 (3.2)31.3 (3.2)31.1 (3.3)31.4 (3.2)31.1 (3.3) BMIkg/m223.94 (4.12)24.11 (4.09)23.67 (4.46)23.80 (4.65)23.80 (4.29)23.95 (4.38) Oocytesn9.0 (4.6)8.6 (4.2)9.8 (4.1)10.9 (4.2)9.4 (4.4)9.7 (4.3) retrieved Good qualityn2.7 (2.2)2.5 (1.9)2.3 (1.6)2.7 (2.0)2.5 (2.0)2.6 (2.0) embryos P4 hCG day nmol/L 2.0 (1.3)1.8 (1.0)1.9 (1.0)1.9 (1.0)2.0 (1.2)1.9 (1.0) P4 ET daynmol/L 316 (233)295 (130)393 (189)409 (191)355 (215)352 (173)